Neuromuscular Disease
RSSArticles
-
Hypothermia After Cardiac Arrest: A Neurological Perspective
-
New Treatments for Vascular Dementia?
-
Special Report: A Review of the 54th Annual Meeting of the American Academy of Neurology
-
Optimal Dosing of Interferon in MS
-
Chemotherapy in Adult High-Grade Glioma
-
Can a Protective Interstitial CNS Drug Prevent or Slow the Damage of ALS?
-
Analgesic Options Using Antiepileptic Medication
-
A Newly Discovered Genetic Cause of Alzheimer’s Disease Mutations of TREM2
Inflammation is thought to play a role in alzheimers disease (AD) pathogenesis. Evidence of inflammation is seen in AD brains, including activated microglia, cytokines, and complement components. -
Clinical Briefs in Primary Care supplement
-
Subcutaneous IVIG for Chronic Inflammatory Demyelinating Polyneuropathy
s the subcutaneous administration of immunoglobulin (SCIG) as safe and effective as intravenous immunoglobulin (IVIG) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) as it is for multifocal motor neuropathy and primary immune disorders?